The role of nuclear factor erythroid 2-related factor 2 (NRF2) in arsenic toxicity
Journal of Environmental Sciences · 2025-04 · 150 · 632-644
DOI: 10.1016/j.jes.2024.02.027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Environmental Sciences, 2025-04. Verfasst von Sara R El-Mahrouk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada; Faculty of Pharmacy, Tanta University, Tan…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Arsenic, Oxidative Stress. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Arsenic, a naturally occurring toxic element, manifests in various chemical forms and is widespread in the environment. Exposure to arsenic is a well-established risk factor for an elevated incidence of various cancers and chronic diseases. The crux of arsenic-mediated toxicity lies in its ability to induce oxidative stress, characterized by an unsettling imbalance between oxidants and antioxidants, accompanied by the rampant generation of reactive oxygen species and free radicals. In response to this oxidative turmoil, cells deploy their defense mechanisms, prominently featuring the redox-sensitive transcription factor known as nuclear factor erythroid 2-related factor 2 (NRF2). NRF2 stands as a primary guardian against the oxidative harm wrought by arsenic. When oxidative stress activates NRF2, it orchestrates a symphony of downstream antioxidant genes, leading to the activation of pivotal antioxidant enzymes like glutathione-S-transferase, heme oxygenase-1, and NAD(P)H: quinone oxidoreductase 1. This comprehensive review embarks on the intricate and diverse ways by which various arsenicals influence the NRF2 antioxidant pathway and its downstream targets, shedding light on their roles in defending against arsenic exposure toxic effects. It offers valuable insights into targeting NRF2 as a strategy for safeguarding against or treating the harmful and carcinogenic consequences of arsenic exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada; Faculty of Pharmacy, Tanta University, Tanta, Gharbia, Egypt.
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada. Electronic address: aelkadi@ualberta.ca.
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
El-Mahrouk, S. R., El-Ghiaty, M. A., & El-Kadi, A. O. S. (2025). The role of nuclear factor erythroid 2-related factor 2 (NRF2) in arsenic toxicity. Journal of Environmental Sciences, 150, 632-644. https://doi.org/10.1016/j.jes.2024.02.027
Vancouver
El-Mahrouk SR, El-Ghiaty MA, El-Kadi AOS. The role of nuclear factor erythroid 2-related factor 2 (NRF2) in arsenic toxicity. Journal of Environmental Sciences. 2025;150:632-644. doi:10.1016/j.jes.2024.02.027
BibTeX
@article{ElMahrouk2025,
author = {El-Mahrouk, Sara R and El-Ghiaty, Mahmoud A and El-Kadi, Ayman O S},
title = {The role of nuclear factor erythroid 2-related factor 2 (NRF2) in arsenic toxicity},
journal = {Journal of Environmental Sciences},
year = {2025},
volume = {150},
pages = {632--644},
doi = {10.1016/j.jes.2024.02.027}
}
EUVIMED